Skip to content

This Site is Intended for Healthcare Professionals Only

Search AI Powered

Latest Stories

Submit Guest Post

Weight-loss drugs reshape UK grocery spending as household use reaches 2.6 million adults

GLP-1 medicines are changing British shopping habits, with more than £1 billion in grocery spending displaced as pill formats and male users drive adoption

Weight loss drugs

Growing use of GLP-1 weight-loss medicines is changing consumer purchasing patterns, prompting food retailers to reconsider product ranges and portion sizes.

iStock

The growing use of GLP-1 weight-loss medicines is reshaping Britain's grocery market, with new research estimating that more than £1 billion in spending has been displaced as consumers change their eating and shopping habits.

The number of households in Great Britain with at least one GLP-1 user increased from 6.3 per cent in February 2026 to 8.5 per cent in August, equivalent to around 2.6 million adults, according to Worldpanel by Numerator.


The latest findings suggest that users are now present in as many British households as vegetarians and pescatarians combined, highlighting how quickly the medicines are becoming part of mainstream consumer behaviour.

Worldpanel has tracked the impact of GLP-1 medicines on purchasing patterns since March 2024. Its fourth wave of research draws on a sample of 9,629 households.

The changing user profile is also significant. Men accounted for 32 per cent of GLP-1 users in August, compared with 23 per cent in February. The number of male users nearly doubled over the period, rising from 440,000 to 830,000.

Oral formats are also gaining ground. Despite receiving recent approval from the Medicines and Healthcare products Regulatory Agency in June 2026, pill-based treatments already account for 11.2 per cent of GLP-1 users.

Nishita Pattni, senior consultant at Worldpanel by Numerator, said adoption had accelerated over the six months to August, with user numbers rising almost as much as they had during the whole of the previous year.

She said daily pills could make treatment easier for people who preferred not to use injections, while growing adoption among men was likely to expand the medicines' appeal.

How are GLP-1 medicines changing grocery spending?

The estimated impact on grocery spending has passed £1 billion, compared with £780 million in June. The research also found that users had bought 415 million fewer packs, equivalent to an estimated £389 in annual grocery spending displaced from each user household.

However, the shift is not simply about consumers buying less. Purchasing patterns are changing across categories, creating different outcomes for food and drink retailers.

Alcohol spending among GLP-1 user households has fallen 15 per cent more than in non-user households. Spending on crisps has also declined by 15 per cent, reflecting reduced purchases of some snack and indulgence products.

Other categories are benefiting. Frozen ready meals recorded a 30 per cent increase in volume among users, while hot chocolate and malt drinks saw spending rise by 22 per cent and volumes increase by 16 per cent.

The figures suggest that although some consumers are reducing impulse purchases, convenient and portion-controlled products continue to find demand.

The changes are also extending beyond food shopping. GLP-1 users spent an estimated £78 million more than expected on health and beauty products in the first year after starting treatment. Around 30 per cent also reported spending more on clothing and footwear.

Chantel Kennaugh, head of public sector and nutrition at Worldpanel by Numerator, said retailers needed to look beyond the overall decline in grocery spending and understand how consumer needs were changing.

She suggested clearer nutritional labelling, including information on protein content, and greater availability of smaller portion sizes as ways retailers could respond without excluding consumers using weight-loss medicines.

Worldpanel estimates that GLP-1 use could exceed 10 per cent of Great Britain's households in 2027.

For food manufacturers and retailers, the implications extend beyond a change in demand for individual products. The growth of this consumer group could influence product development, packaging, portion sizes and nutritional positioning as businesses adapt to changing purchasing habits.